Drug firm Zydus Cadila has received approval from the US health regulator to market Acamprosate calcium delayed-release tablets used for... ...http://www.business-standard.com/article/pti-stories/zydus-cadila-gets-usfda-nod-to-market-alcohol-abstinence-drug-117052700761_1.html
Posted by Equitymaster After opening the day on a positive note, the Indian share markets have continued the momentum and are trading at record... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/TZc1kfujDBs/tm.asp
Dr Reddy's Laboratories gained 0.54% to Rs 2,440.50 at 11:45 IST on BSE after the company said that US drug regulator completed the audit of its... ...http://www.business-standard.com/article/news-cm/dr-reddy-s-gets-healthier-after-usfda-clears-plant-after-audit-117052600373_1.html
Posted by Equitymaster Stock markets in Asia are lower today despite major oil producers agreeing to extend output cut for an additional nine... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/uZJopHhK8OM/tm.asp
Dr Reddy's Laboratories today said the US health regulator USFDA has issued no observations after inspecting its formulations plant in Andhra Pradesh. ...http://www.dnaindia.com/business/report-usfda-inspects-plant-no-observations-issued-dr-reddy-s-2450817
SORBEAD INDIA is offering a wide...
Miocon is pleased to introduce...